 eYugoslavia.com |
APP Pharmaceuticals Announces Approval of Preservative-Free Methotrexate …
SunHerald.com SCHAUMBURG, Ill. — APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the US Food and Drug Administration (FDA) to market preservative-free … APP Pharmaceuticals receives marketing approval for Methotrexate Injection |
View full post on pharmaceutical – Google News
